| Income Statement |
| Operating Expenses | 2.35M |
|
| Research and Development Expense | 1.44M |
| Selling, General and Administrative Expense | 911.32K |
| Operating Income | -2.35M |
| Net Income | -2.32M |
| Net Income Common Stock | -2.32M |
| Net Income Common Stock (USD) | -2.32M |
| Consolidated Income | -2.32M |
| Earnings per Basic Share | -1.12 |
| Earnings per Basic Share (USD) | -1.12 |
| Earnings per Diluted Share | -1.12 |
| Earning Before Interest & Taxes (EBIT) | -2.32M |
| Earning Before Interest & Taxes (USD) | -2.32M |
| Weighted Average Shares | 2.08M |
| Weighted Average Shares Diluted | 2.08M |
| Balance Sheet |
| Cash and Equivalents | 9.60M |
| Cash and Equivalents (USD) | 9.60M |
| Current Assets | 9.81M |
| Property, Plant & Equipment Net | 1.71M |
| Total Assets | 11.53M |
| Debt Current | 73.44K |
| Total Debt | 73.44K |
| Current Liabilities | 2.12M |
| Total Liabilities | 2.12M |
| Accumulated Retained Earnings (Deficit) | -45.76M |
| Shareholders Equity | 9.41M |
| Shareholders Equity (USD) | 9.41M |
| Assets Non-Current | 1.72M |
| Total Debt (USD) | 73.44K |
| Liabilities Non-Current | 2.42K |
| Trade and Non-Trade Payables | 674.09K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 50.40K |
| Net Cash Flow from Financing | 7.56M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 5.91M |
| Capital Expenditure | -142.77K |
| Issuance (Purchase) of Equity Shares | 7.56M |
| Issuance (Repayment) of Debt Securities | -1.07K |
| Net Cash Flow from Investing | -142.77K |
| Net Cash Flow from Operations | -1.50M |